August 2020 - BioMedWire (BMW)

MondayAug 31, 2020 1:00 pm

Why Healthcare Professionals Should Utilize Social Media

As you join medical school, one of the first things that you will undergo during the orientation period is watching instructional videos. The videos are always about social media and what you should do and what you should not do as an upcoming healthcare professional. For long periods now, healthcare worker, were advised against the use of social media, especially when at work. As a physician, there are some things that you are not supposed to do at all costs. For instance, you are not supposed to post the patients’ personal information, expose medically vital information, and disclose the patient's…

MondayAug 31, 2020 10:55 am

Steps to Take Before Drug Patents Expire

It would be best if you always had strategies that you can use when your drug patent is about to lose its exclusivity. As your drug patent expires and the generic competition emerges, your branded drugs will automatically lose more than 40% of their sales to generic formulations. It is therefore always essential to come up with strategies for you to have a soft landing spot in case your drug patent expires. These are some of the steps you may consider taking as your drug patent approaches its expiry: The conventional therapy against the return hits that come with the…

FridayAug 28, 2020 2:30 pm

Mistakes to Avoid When Planning a Drug Launch

Launching a new product is always a huge undertaking. Though your company has managed to enter the market on several occasions, not every moment will resemble or will be successful as other moments. As you launch your new drug into the market, several factors must be put in place to ensure that your drug launch is successful. Note that without following proper launching procedures, your entry into the market may fail. Though mistakes are sometimes inevitable, you should try to avoid them during this important function. If your firm is gearing towards launching its novel drug or expanding into new…

FridayAug 28, 2020 9:15 am

Maximizing the Value of Drug Patents Before Losing Exclusivity

When you lose your drug patent exclusivity, it does not mean that you have lost your income when. Your anxiety may be awakened if only a new drug competitor enters the market. However, you can still ensure that your product still reaps big profits even if your drug patent is approaching loss of exclusivity. These are some of the ways you can maximize product value as a loss of exclusivity looms: Early Planning You should start developing your loss of exclusivity plans for your product at least two years before your drug patent expires. You can begin to implement this…

ThursdayAug 27, 2020 3:15 pm

Pandemic Warning Signs We Missed

You never knew that there would be a pandemic, and you had never seen anything like this before. No one would ever have imagined a thing like this will strike. However, before COVID-19 hit the world, several people had already issued warnings about the pandemic. Those people included medical experts, famous authors, and presidents. These people were issuing warnings in conferences, televisions, and government reports. Here are some of the seven warning signs about the pandemic that we ignored: UNC Specialists warned about the emergence of coronavirus (2015-2016) A famous coronavirus epidemiologist at the University of North Carolina had been…

ThursdayAug 27, 2020 10:45 am

5 Factors to Consider When Investing in a Drug Company

As your drug patent rights lapse, you can lose billions of money as your new competitors enter the market. This is the main reason why several investors always put their concentration on drug patent rights during the evaluation of drug companies. To help you make better investment decisions, here are some of the main factors to put into consideration if you want to invest in drug companies: Seek Orphan Drug and Non-Patent Administrative Exclusives In several states, governments are always using the regulatory agencies’ non-patent individuality, such as those in orphan drugs. They use those exclusivities to incentivize the production…

WednesdayAug 26, 2020 1:08 pm

Predictive Oncology Inc.’s (NASDAQ: POAI) Exclusive Resources Provide Personal Profiling, Tools to Improve Patient Outcomes

POAI, Helomics builds AI-driven models that predict drug response, patient outcome Company tests patient tumor, generates comprehensive picture that oncologists use to individualize therapy Key to individualized insight is POAI’s Tumor Drug Response Profiling (“TDRP”) platform, NGS-based genomic profiling, unmatched cancer knowledge base Guided by the mantra that “cancer is personal — we believe therapy should be too,” Predictive Oncology (NASDAQ: POAI) subsidiary Helomics focus on building AI-driven models that will predict drug response and patient outcome of individual tumors. With the largest tumor inventory in the world, POAI leads the way in providing a functional precision medicine approach that harnesses…

WednesdayAug 26, 2020 12:15 pm

Ethical Considerations in Human Biospecimen Collection

As researchers are frantically looking for a COVID-19 vaccine and other treatments, safety, and health ethical issues of patients must be highly considered. Some ethical issues, like the anonymity of patients, must be handled with proper attention so as not to affect the esteem of any individual. As a researcher, before using any patient in your clinical trials, you must first obtain written consent from them. You may risk your job in acquiring the biospecimen from patients if you do not seek permission from them. Also, you should familiarize yourself with your country’s legal and ethical laws regarding human subjects.…

WednesdayAug 26, 2020 9:30 am

Artificial Intelligence Could Help Eradicate COVID-19

The use of artificial intelligence (“AI”) has increased over the years. This has enabled researchers to have the computing powers of higher orders than what was there when COVID-19 first struck. Today, artificial intelligence has significantly been used to find different patterns within large information sets. Furthermore, artificial intelligence is instrumental in helping you to understand better any information that is not characterized. AI can also be used in predicting trends and patterns of the various phenomenon, and this could hold the key to finding a solution to COVID-19. Incorporating Artificial Intelligence in COVID-19 research Artificial intelligence works even better…

TuesdayAug 25, 2020 2:30 pm

Florida Approves Release of Engineered Mosquitoes to Combat Viral Diseases

Some of the infectious ailments spread by mosquitoes such as yellow fever, Zika, Chikungunya, and dengue are growing concerns in the U.S. and globally. To successfully combat these diseases, you will have to deal with their vectors effectively. Recently, permission was granted to the piloting program in Florida to release genetically modified mosquitoes to the environment. The initiative is to help combat the spread of these infectious diseases. The proponent of this project is Oxitec which aims at controlling and combating insect pests such as the medflies, mosquitoes, and diamondback moths. The project has been fully supported by the Florida…